(Q40016089)

English

Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1.

scientific article published on 6 February 2008

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Recognition of naturally processed and ovarian cancer reactive CD8+ T cell epitopes within a promiscuous HLA class II T-helper region of NY-ESO-1. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1 reference

based on heuristic

inferred from title

9

object named as

Kunle Odunsi

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

7

object named as

Sacha Gnjatic

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

5

object named as

Gerd Ritter

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

8

object named as

Lloyd J Old

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Junko Matsuzaki

1

object named as

Junko Matsuzaki

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Shashikant B Lele

4

object named as

Shashikant Lele

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Protul A Shrikant

6

object named as

Protul A Shrikant

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

author name string

Feng Qian

2

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Immanuel Luescher

3

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

publication date

6 February 2008

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

57

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

8

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

1185-1195

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

HLA-DP4, the most frequent HLA II molecule, defines a new supertype of peptide-binding specificity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0450-4

21 January 2018

Multiepitope CD8(+) T cell response to a NY-ESO-1 peptide vaccine results in imprecise tumor targeting

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0450-4

21 January 2018

Striking immunodominance hierarchy of naturally occurring CD8+ and CD4+ T cell responses to tumor antigen NY-ESO-1.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0450-4

21 January 2018

Cross-reactive CD4+ T cells against one immunodominant tumor-derived epitope in melanoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-008-0450-4

21 January 2018

Identifiers

10.1007/S00262-008-0450-4

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Dimensions Publication ID

0 references

release_a55ujrqwtngulb3qvc2ugdikye

1 reference

https://api.fatcat.wiki/v0/release/a55ujrqwtngulb3qvc2ugdikye

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40016089&oldid=2203319743"